- Home
- BRFH vs LPCN Comparison
BRFH vs LPCN Comparison
Compare BRFH & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRFH
- LPCN
- Stock Information
- Founded
- BRFH 2005
- LPCN 1997
- Country
- BRFH United States
- LPCN United States
- Employees
- BRFH N/A
- LPCN N/A
- Industry
- BRFH Packaged Foods
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- BRFH Consumer Staples
- LPCN Health Care
- Exchange
- BRFH Nasdaq
- LPCN Nasdaq
- Market Cap
- BRFH 38.3M
- LPCN 36.8M
- IPO Year
- BRFH N/A
- LPCN N/A
- Fundamental
- Price
- BRFH $2.89
- LPCN $5.12
- Analyst Decision
- BRFH Strong Buy
- LPCN Strong Buy
- Analyst Count
- BRFH 1
- LPCN 1
- Target Price
- BRFH $4.50
- LPCN $10.00
- AVG Volume (30 Days)
- BRFH 13.8K
- LPCN 31.0K
- Earning Date
- BRFH 10-24-2024
- LPCN 11-07-2024
- Dividend Yield
- BRFH N/A
- LPCN N/A
- EPS Growth
- BRFH N/A
- LPCN N/A
- EPS
- BRFH N/A
- LPCN N/A
- Revenue
- BRFH $9,851,000.00
- LPCN $7,922,926.00
- Revenue This Year
- BRFH $51.72
- LPCN N/A
- Revenue Next Year
- BRFH $38.85
- LPCN N/A
- P/E Ratio
- BRFH N/A
- LPCN N/A
- Revenue Growth
- BRFH 29.01
- LPCN N/A
- 52 Week Low
- BRFH $1.00
- LPCN $2.38
- 52 Week High
- BRFH $4.61
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- BRFH 59.53
- LPCN 46.71
- Support Level
- BRFH $2.46
- LPCN $4.79
- Resistance Level
- BRFH $2.71
- LPCN $6.16
- Average True Range (ATR)
- BRFH 0.25
- LPCN 0.56
- MACD
- BRFH 0.06
- LPCN -0.11
- Stochastic Oscillator
- BRFH 91.70
- LPCN 28.61
About BRFH Barfresh Food Group Inc.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.